AIM: Our aim was to investigate the effectiveness of aminoguanidine (AMG), an inducible nitric oxide synthase inhibitor, and hyperbaric oxygen (HBO) treatment in an experimental colitis model. METHODS: We induced colitis in rats. In the control group, we applied 2 ml serum physiologic intraperitoneally for 7 days. In the HBO group, 100% oxygen at 2.4 atm pressure was applied for 7 days. In the AMG group, 100 mg/kg AMG was applied intraperitoneally for 7 days. In the HBO + AMG group, HBO and AMG were applied, respectively. At the end of 7 days, rats were sacrificed and the distal 10 cm part of colon was examined macro- and microscopically. RESULTS: Severity of colitis and NO activities were reduced by AMG, HBO, and HBO + AMG application. There was histologically significant improvement, especially in the HBO + AMG group. CONCLUSIONS: Both HBO and AMG were significantly effective in preventing weight loss, reducing NO activities, and severity of colitis, when comparing HBO and AMG separately.
AIM: Our aim was to investigate the effectiveness of aminoguanidine (AMG), an inducible nitric oxide synthase inhibitor, and hyperbaric oxygen (HBO) treatment in an experimental colitis model. METHODS: We induced colitis in rats. In the control group, we applied 2 ml serum physiologic intraperitoneally for 7 days. In the HBO group, 100% oxygen at 2.4 atm pressure was applied for 7 days. In the AMG group, 100 mg/kg AMG was applied intraperitoneally for 7 days. In the HBO + AMG group, HBO and AMG were applied, respectively. At the end of 7 days, rats were sacrificed and the distal 10 cm part of colon was examined macro- and microscopically. RESULTS: Severity of colitis and NO activities were reduced by AMG, HBO, and HBO + AMG application. There was histologically significant improvement, especially in the HBO + AMG group. CONCLUSIONS: Both HBO and AMG were significantly effective in preventing weight loss, reducing NO activities, and severity of colitis, when comparing HBO and AMG separately.
Authors: E Kankuri; M Hämäläinen; M Hukkanen; P Salmenperä; E Kivilaakso; H Vapaatalo; E Moilanen Journal: Scand J Gastroenterol Date: 2003-02 Impact factor: 2.423
Authors: G A Filntisis; R E Moon; K L Kraft; J C Farmer; R L Scher; C A Piantadosi Journal: Ann Otol Rhinol Laryngol Date: 2000-06 Impact factor: 1.547
Authors: Kevin P Pavlick; F Stephen Laroux; John Fuseler; Robert E Wolf; Laura Gray; Jason Hoffman; Matthew B Grisham Journal: Free Radic Biol Med Date: 2002-08-01 Impact factor: 7.376
Authors: Charalambos J Pilichos; Ilias A Kouerinis; George C Zografos; Dimiris P Korkolis; Athena A Preza; Maria Gazouli; Evangelos I Menenakos; Antonios E Loutsidis; Flora Zagouri; Vassilis G Gorgoulis; Constantin I Fotiadis Journal: In Vivo Date: 2004 Jul-Aug Impact factor: 2.155
Authors: Rogério S Parra; Alexandre H Lopes; Eleonora U Carreira; Marley R Feitosa; Fernando Q Cunha; Sérgio B Garcia; Thiago M Cunha; José J R da Rocha; Omar Féres Journal: Med Gas Res Date: 2015-04-16